Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunder Mudaliar

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
Diabetes Care|February 16, 2013
Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled studyDavid Polidori, Sue Sha, Sunder Mudaliar, et al.
Archives of General Psychiatry|July 6, 2005
Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrumentBarton W Palmer, Laura B Dunn, Paul S Appelbaum, et al.
Metabolism: Clinical and Experimental|May 22, 2003
Regulation of skeletal muscle morphology in type 2 diabetic subjects by troglitazone and metformin: relationship to glucose disposalOdile Mathieu-Costello, Alice Kong, Theodore P Ciaraldi, et al.
Diabetes|January 29, 2002
Troglitazone but not metformin restores insulin-stimulated phosphoinositide 3-kinase activity and increases p110beta protein levels in skeletal muscle of type 2 diabetic subjectsYoung-Bum Kim, Theodore P Ciaraldi, Alice Kong, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 8, 2006
Tissue-specific expression and regulation of GSK-3 in human skeletal muscle and adipose tissueTheodore P Ciaraldi, Deborah K Oh, Louis Christiansen, et al.
The Journal of Clinical Endocrinology and Metabolism|December 13, 2003
Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clampMargaret Sowell, Nitai Mukhopadhyay, Patrizia Cavazzoni, et al.
Current Medical Research and Opinion|July 23, 2009
Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetesMichael R Jones, Sunder Mudaliar, Eric Hernandez-Triana, et al.
Diabetes Care|October 2, 2014
Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot studyRobert R Henry, Julio Rosenstock, Steven Edelman, et al.
The Journal of Clinical Psychiatry|December 11, 2012
Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomizationHua Jin, Pei-an Betty Shih, Shahrokh Golshan, et al.
Diabetes Care|August 29, 2025
Impact of Parental or First-Degree Family History of Diabetes on Diabetes Incidence and Progression During Long-term Follow-up in the Diabetes Prevention Program Outcomes StudySamuel Dagogo-Jack, Erin J Kazemi, Lindsay Doherty, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Diabetes Care|February 16, 2013
Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled studyDavid Polidori, Sue Sha, Sunder Mudaliar, et al.
Archives of General Psychiatry|July 6, 2005
Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrumentBarton W Palmer, Laura B Dunn, Paul S Appelbaum, et al.
Metabolism: Clinical and Experimental|May 22, 2003
Regulation of skeletal muscle morphology in type 2 diabetic subjects by troglitazone and metformin: relationship to glucose disposalOdile Mathieu-Costello, Alice Kong, Theodore P Ciaraldi, et al.
Diabetes|January 29, 2002
Troglitazone but not metformin restores insulin-stimulated phosphoinositide 3-kinase activity and increases p110beta protein levels in skeletal muscle of type 2 diabetic subjectsYoung-Bum Kim, Theodore P Ciaraldi, Alice Kong, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 8, 2006
Tissue-specific expression and regulation of GSK-3 in human skeletal muscle and adipose tissueTheodore P Ciaraldi, Deborah K Oh, Louis Christiansen, et al.
The Journal of Clinical Endocrinology and Metabolism|December 13, 2003
Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clampMargaret Sowell, Nitai Mukhopadhyay, Patrizia Cavazzoni, et al.
Current Medical Research and Opinion|July 23, 2009
Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetesMichael R Jones, Sunder Mudaliar, Eric Hernandez-Triana, et al.
Diabetes Care|October 2, 2014
Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot studyRobert R Henry, Julio Rosenstock, Steven Edelman, et al.
The Journal of Clinical Psychiatry|December 11, 2012
Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomizationHua Jin, Pei-an Betty Shih, Shahrokh Golshan, et al.
Diabetes Care|August 29, 2025
Impact of Parental or First-Degree Family History of Diabetes on Diabetes Incidence and Progression During Long-term Follow-up in the Diabetes Prevention Program Outcomes StudySamuel Dagogo-Jack, Erin J Kazemi, Lindsay Doherty, et al.
Pageof 9